It is mediated by kinesin-1, which binds to mitochondria via anchoring proteins including the microtubule-associated motors dynein-dynactin, the Ca 2+ -dependent mitochondrial Rho GTPase 1 (Miro1), and the trafficking kinesin proteins 1 and 2 [45]
This work was supported by the Science and Technology Department of Sichuan Province (2024NSFSC0687), Science and Technology Program of Chengdu Medical College (CYZZD2201), Science and Technology Program of the First Affiliated Hospital of Chengdu Medical College (CYFY2021ZD01), and the CMC Excellent Talent Program (2024qnGzn02)
Warnings and Cautions BPC-157 lacks regulatory approval for human use in most countries, and its safety profile in humans remains incompletely understood due to limited clinical trials
Peptide Degradation and Contamination Risk: BPC-157 sourced from unregulated research suppliers carries the risk of contamination, incorrect peptide sequencing, or degraded compound from improper storage, introducing unpredictable biological effects beyond the peptide's known pharmacology
Every product is third-party tested through ISURA for over 800 contaminants including pesticides and heavy metals
